Table 1. Trends in Leprosy Elimination Indicators in Yunnan, China, from 1990 to 2019.
| Year | New cases detected | Relapsed cases detected | NCDR per 100,000 population | MB proportion (%) | Children proportion (%) | Female proportion (%) | G2D proportion (%) | G2D rate per 100,000 population | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | 11052 | 514 | 0.89 | 7330 | 66.3% | 452 | 4.1% | 3346 | 30.1% | 2356 | 21.3% | 0.19 |
| 1990 | 703 | 44 | 1.93 | 463 | 65.9% | 26 | 3.7% | 195 | 27.7% | 197 | 28.0% | 0.54 |
| 1991 | 590 | 23 | 1.58 | 404 | 68.5% | 22 | 3.7% | 148 | 25.1% | 147 | 24.9% | 0.39 |
| 1992 | 621 | 30 | 1.65 | 413 | 66.5% | 29 | 4.7% | 170 | 27.4% | 160 | 25.8% | 0.42 |
| 1993 | 479 | 36 | 1.26 | 351 | 73.3% | 17 | 3.5% | 130 | 27.1% | 124 | 25.9% | 0.33 |
| 1994 | 479 | 25 | 1.25 | 336 | 70.1% | 21 | 4.4% | 136 | 28.4% | 126 | 26.3% | 0.33 |
| 1995 | 433 | 26 | 1.12 | 316 | 73.0% | 16 | 3.7% | 111 | 25.6% | 120 | 27.7% | 0.31 |
| 1996 | 494 | 26 | 1.27 | 336 | 68.0% | 23 | 4.7% | 150 | 30.4% | 107 | 21.7% | 0.28 |
| 1997 | 362 | 22 | 0.92 | 256 | 70.7% | 22 | 6.1% | 127 | 35.1% | 83 | 22.9% | 0.21 |
| 1998 | 735 | 21 | 1.85 | 409 | 55.6% | 74 | 10.1% | 221 | 30.1% | 124 | 16.9% | 0.31 |
| 1999 | 491 | 22 | 1.19 | 337 | 68.6% | 22 | 4.5% | 151 | 30.8% | 89 | 18.1% | 0.22 |
| 2000 | 382 | 15 | 0.94 | 268 | 70.2% | 16 | 4.2% | 113 | 29.6% | 71 | 18.6% | 0.17 |
| 2001 | 388 | 17 | 0.94 | 247 | 63.7% | 17 | 4.4% | 117 | 30.2% | 75 | 19.3% | 0.18 |
| 2002 | 358 | 18 | 0.86 | 232 | 64.8% | 13 | 3.6% | 101 | 28.2% | 66 | 18.4% | 0.16 |
| 2003 | 353 | 11 | 0.85 | 248 | 70.3% | 13 | 3.7% | 121 | 34.3% | 61 | 17.3% | 0.15 |
| 2004 | 337 | 22 | 0.80 | 217 | 64.4% | 15 | 4.5% | 104 | 30.9% | 67 | 19.9% | 0.16 |
| 2005 | 407 | 9 | 0.91 | 265 | 65.1% | 11 | 2.7% | 124 | 30.5% | 70 | 17.2% | 0.16 |
| 2006 | 366 | 8 | 0.82 | 224 | 61.2% | 11 | 2.5% | 117 | 32.0% | 74 | 20.2% | 0.16 |
| 2007 | 344 | 11 | 0.76 | 230 | 66.9% | 4 | 1.2% | 102 | 29.7% | 66 | 19.2% | 0.15 |
| 2008 | 393 | 16 | 0.86 | 232 | 59.0% | 12 | 3.1% | 114 | 29.0% | 63 | 16.0% | 0.14 |
| 2009 | 321 | 20 | 0.70 | 228 | 71.0% | 8 | 2.5% | 116 | 36.1% | 62 | 19.3% | 0.14 |
| 2010 | 228 | 4 | 0.50 | 135 | 59.2% | 7 | 3.1% | 72 | 31.6% | 73 | 32.0% | 0.16 |
| 2011 | 283 | 10 | 0.62 | 172 | 60.8% | 7 | 2.5% | 103 | 36.4% | 83 | 29.3% | 0.18 |
| 2012 | 230 | 16 | 0.50 | 147 | 63.9% | 10 | 4.3% | 72 | 31.3% | 54 | 23.5% | 0.12 |
| 2013 | 241 | 9 | 0.52 | 155 | 64.3% | 6 | 2.5% | 81 | 33.6% | 43 | 17.8% | 0.09 |
| 2014 | 208 | 10 | 0.44 | 136 | 65.4% | 6 | 2.9% | 68 | 32.7% | 38 | 18.3% | 0.08 |
| 2015 | 187 | 6 | 0.40 | 122 | 65.2% | 10 | 5.3% | 56 | 29.9% | 30 | 16.0% | 0.06 |
| 2016 | 170 | 11 | 0.36 | 109 | 64.1% | 8 | 4.7% | 56 | 32.9% | 28 | 16.5% | 0.06 |
| 2017 | 159 | 11 | 0.33 | 112 | 70.4% | 1 | 0.6% | 52 | 32.7% | 20 | 12.6% | 0.04 |
| 2018 | 174 | 9 | 0.36 | 129 | 74.1% | 3 | 1.7% | 67 | 38.5% | 18 | 10.3% | 0.04 |
| 2019 | 136 | 6 | 0.28 | 101 | 74.3% | 2 | 1.5% | 51 | 37.5% | 17 | 12.5% | 0.04 |
NCDR = New case detection rate, MB = Multibacillary, G2D = Grade 2 disability.